Stem-cell therapy in ST-segment elevation myocardial infarction with reduced ejection fraction: A multicenter, double-blind randomized trial

Predicting Persistent Left Ventricular Dysfunction Following Myocardial Infarction

(2016) Gabriel C. Brooks et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

A randomized double-blind control study of early intra-coronary autologous bone marrow cell infusion in acute myocardial infarction: the REGENERATE-AMI clinical trial

(2015) Fizzah Choudry et al.   EUROPEAN HEART JOURNAL

Comparison of Different Bone Marrow–Derived Stem Cell Approaches in Reperfused STEMI

(2015) J. Alberto San Roman et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

(2015)   LANCET

Discrepancies in autologous bone marrow stem cell trials and enhancement of ejection fraction (DAMASCENE): weighted regression and meta-analysis

(2014) A. N. Nowbar et al.   BMJ-British Medical Journal

Current Evidence Base for Use of the Implantable Cardioverter–Defibrillator

(2013) Stefan H. Hohnloser et al.   CIRCULATION

Intracoronary Injection of Bone Marrow–Derived Mononuclear Cells Early or Late After Acute Myocardial Infarction

(2013) Daniel Sürder et al.   CIRCULATION

Risk stratification after myocardial infarction: is left ventricular ejection fraction enough to prevent sudden cardiac death?

(2013) Nikolaos Dagres et al.   EUROPEAN HEART JOURNAL

Utilização de terapêuticas comprovadamente úteis no tratamento da coronariopatia aguda: comparação entre diferentes regiões brasileiras. Análise do Registro Brasileiro de Síndromes Coronarianas Agudas (BRACE - Brazilian Registry on Acute Coronary Syndromes)

(2012) José Carlos Nicolau et al.   Arquivos Brasileiros de Cardiologia

Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial

(2012) Raj R Makkar et al.   LANCET

Effect of Intracoronary Delivery of Autologous Bone Marrow Mononuclear Cells 2 to 3 Weeks Following Acute Myocardial Infarction on Left Ventricular Function

(2011) Jay H. Traverse   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Intracoronary infusion of bone marrow-derived selected CD34+CXCR4+ cells and non-selected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT) Trial

(2009) Michał Tendera et al.   EUROPEAN HEART JOURNAL

A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial Infarction

(2009) Joshua M. Hare et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Multicenter double blind trial of autologous bone marrow mononuclear cell transplantation through intracoronary injection post acute myocardium infarction – MiHeart/AMI study

(2008) Hans F R Dohmann et al.   Trials